CURE’s thyroid cancer page is an extensive resource of cancer information featuring the latest thyroid cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on thyroid cancer.
July 28th 2021, 1:58pm
The pros and cons of conducting pathology assessments for comprehensive biomarker tests in central laboratories versus local laboratories.
July 21st 2021, 5:48pm
Current barriers that impact patient access to comprehensive biomarker testing in the community and efforts underway to help advocate for increased accessibility to molecular assays moving forward.
July 21st 2021, 4:05pm
Resources available to support patients and community oncologists who are interested in learning more and gaining access to comprehensive biomarker testing.
June 23rd 2021, 2:06pm
Lori J. Wirth, MD, describes what information she looks for from results of molecular testing that help inform treatment for her patients with thyroid cancer.
June 23rd 2021, 1:58pm
Andrea Ferris, of the LUNGevity Foundation, explains why shared decision-making is important when recommending molecular testing to patients with lung or thyroid cancer and highlights resources provided through her organization that support patients and health care professionals.
June 16th 2021, 3:21pm
Common questions asked by patients with lung or thyroid cancer who have been referred for biomarker testing and advice for setting expectations from test results.
June 16th 2021, 3:15pm
Drs Benjamin Levy and Lori J. Wirth comment on the current role of liquid biopsies in lung and thyroid cancer.
June 9th 2021, 2:45pm
Recommendations for selecting appropriate patients for comprehensive genomic profiling and navigating through the testing process.
June 9th 2021, 2:35pm
Drs Benjamin Levy and Lori J. Wirth describe how they currently utilize comprehensive genomic profiling to manage patients with non–small cell lung cancer or thyroid cancer.
May 20th 2021, 2:40pm
New research sheds lights on the causes of thyroid cancer, overdiagnosis of PTC
Pancreatic Cancer on the Rise Among Younger Adults
Covering Every FDA Oncology Approval From October 2025
Why ‘There is Hope’ For Patients With Pancreatic Cancer
Walking Through It All: Staying Active With Cancer and Knee Surgery